These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Hepatic venous pressure gradient: to measure or not to measure, that is the question. Sanyal AJ Hepatology; 2000 Nov; 32(5):1175-6. PubMed ID: 11050073 [No Abstract] [Full Text] [Related]
33. Portal hypertension. Update on pathophysiology and management. Chatila R J Med Liban; 2001; 49(2):101-5. PubMed ID: 11910964 [TBL] [Abstract][Full Text] [Related]
34. Circadian variation in portal pressure: appropriate use of non-selective beta blockers in the prevention of variceal bleed. Mann NS; Leung JW Med Hypotheses; 2001 Oct; 57(4):423-5. PubMed ID: 11601861 [TBL] [Abstract][Full Text] [Related]
37. [Non-cardiac indications for administration of molsidomine. Conclusions/perspectives]. May B Med Klin (Munich); 1994 Jul; 89 Suppl 2():75. PubMed ID: 7968915 [No Abstract] [Full Text] [Related]
38. Fate of bradykinin on the rat liver when administered by the venous or arterial route. Gioli-Pereira L; Nascimento EA; Santos EL; Bracht A; Juliano MA; Pesquero JB; Borges DR; Kouyoumdjian M J Gastroenterol Hepatol; 2005 Mar; 20(3):463-73. PubMed ID: 15740493 [TBL] [Abstract][Full Text] [Related]
39. Losartan in preascitic cirrhosis. Castaño G; Viudez P; Sookoian S Am J Gastroenterol; 2004 Nov; 99(11):2282-3. PubMed ID: 15555016 [No Abstract] [Full Text] [Related]
40. Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension. Authors' reply. Dunne P; Young D; Chuah CS; Hayes P; Tripathi D; Leithead J; Smith L; Gaya D; Forrest E; Stanley AJ Aliment Pharmacol Ther; 2022 Jul; 56(1):186-187. PubMed ID: 35689317 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]